Elamparithi Jayamani
Papers
1
Total Citations
99
H-Index
1
About
Elamparithi Jayamani has made pioneering contributions to antimicrobial drug discovery and infectious disease research, with a particular focus on multi-drug resistant pathogens. His most cited work, "Whole Animal Automated Platform for Drug Discovery against Multi-Drug Resistant Staphylococcus aureus" (2014, 99 citations), introduced a revolutionary high-throughput screening method using *Caenorhabditis elegans* as a whole-animal infection model. This platform transformed the search for new antibiotics by enabling rapid, automated testing of compounds against *Staphylococcus aureus*, the leading cause of hospital-acquired infections in the United States. By leveraging the natural pathogenicity of *S. aureus* to *C. elegans*, Jayamani’s approach bypassed traditional in vitro limitations, allowing researchers to identify compounds effective in a living host. This work has been widely cited for its practical impact on drug discovery pipelines and its potential to combat the growing crisis of antimicrobial resistance. Jayamani’s research continues to bridge microbiology, genetics, and pharmacology, offering innovative tools to address urgent global health challenges.
Research Focus
Key Achievements
Top Papers
- 1